CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,014,000 | -10.8% | 44,330 | -21.0% | 0.00% | 0.0% |
| Q1 2017 | $5,619,000 | +55.8% | 56,118 | +67.3% | 0.00% | 0.0% |
| Q4 2016 | $3,607,000 | -80.4% | 33,535 | -77.3% | 0.00% | -75.0% |
| Q3 2016 | $18,383,000 | +232.8% | 147,673 | +184.2% | 0.00% | +300.0% |
| Q2 2016 | $5,524,000 | -33.3% | 51,962 | -28.2% | 0.00% | -50.0% |
| Q1 2016 | $8,280,000 | +11.7% | 72,331 | +38.9% | 0.00% | 0.0% |
| Q4 2015 | $7,416,000 | +40.2% | 52,059 | -11.6% | 0.00% | +100.0% |
| Q3 2015 | $5,288,000 | +628.4% | 58,876 | +833.2% | 0.00% | – |
| Q2 2015 | $726,000 | +30.8% | 6,309 | +8.5% | 0.00% | – |
| Q1 2015 | $555,000 | +53.7% | 5,817 | +8.2% | 0.00% | – |
| Q4 2014 | $361,000 | +38.8% | 5,377 | +11.7% | 0.00% | – |
| Q3 2014 | $260,000 | +550.0% | 4,814 | +434.3% | 0.00% | – |
| Q2 2014 | $40,000 | +29.0% | 901 | +0.1% | 0.00% | – |
| Q1 2014 | $31,000 | +933.3% | 900 | +800.0% | 0.00% | – |
| Q4 2013 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2013 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Segantii Capital Management Ltd | 50,000 | $5,288,000 | 5.80% |
| RUDMAN ERROL M | 37,001 | $3,934,000 | 3.76% |
| INDUS CAPITAL PARTNERS, LLC | 349,210 | $37,128,000 | 3.60% |
| WARBURG PINCUS LLC | 1,312,200 | $139,513,000 | 3.04% |
| SPQ Asia Capital Ltd | 96,000 | $10,206,000 | 2.63% |
| OBERWEIS ASSET MANAGEMENT INC/ | 82,775 | $8,801,000 | 2.62% |
| Ativo Capital Management LLC | 94,074 | $10,002,000 | 2.44% |
| Sensato Investors LLC | 99,764 | $10,607,000 | 1.72% |
| Cormorant Asset Management, LP | 112,867 | $12,000,000 | 1.70% |
| BARING ASSET MANAGEMENT Ltd | 131,284 | $13,958,000 | 1.14% |